Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors as antimalarial agents
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - November 9, 2023 Category: Drugs & Pharmacology Authors: Pinky GehlotVivek K. VyasDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, India Source Type: research

Conjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 30, 2023 Category: Drugs & Pharmacology Authors: Alen KrajncStanislav GobecDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia Source Type: research

N-acetylgalactosamine delivery systems for RNA therapeutics: a patent perspective
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 28, 2023 Category: Drugs & Pharmacology Authors: Hai-Long ZhangLansuo WangCentral International Intellectual Property (Baotou) Co. Ltd, Baotou, China Source Type: research

The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 24, 2023 Category: Drugs & Pharmacology Authors: Pengyun LiBingkun LiNing YangTingting XuZhibing ZhengNational Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing, China Source Type: research

An updated patent review of GLP-1 receptor agonists (2020-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 23, 2023 Category: Drugs & Pharmacology Authors: Weiwen LuZhongbo ZhouNeng JiangJing Hana School of Pharmacy, Youjiang Medical University for Nationalities, Baise, Guangxi, PR Chinab Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, PR Chinac School of Chemistry & Ma Source Type: research

An updated patent review of AKT inhibitors (2020 – present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 21, 2023 Category: Drugs & Pharmacology Authors: Linjie LiYu GuoYang LuYaping XuYan LuXiuping ZhuXiaowu DongJinxin Chea Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. Chinab Department of Pharmacy Source Type: research

G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 19, 2023 Category: Drugs & Pharmacology Authors: Francesca RomanoAnna Di PorzioNunzia IaccarinoGelsomina RiccardiRitamaria Di LorenzoSonia LaneriBruno PaganoJussara AmatoAntonio RandazzoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy Source Type: research

Proteasome inhibitors as anticancer agents
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 17, 2023 Category: Drugs & Pharmacology Authors: Giorgia GazzaroliAndrea AngeliArianna GiacominiRoberto Roncaa Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italyb Neurofarba Department, University of Florence, Sesto Fiorentino, Florence, Italy Source Type: research

Therapeutic treatment strategies for the management of onychomycosis: a patent perspective
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - October 6, 2023 Category: Drugs & Pharmacology Authors: Snigdha Chakraborty SanshitaInderbir SinghChitkara College of Pharmacy, Chitkara University, Punjab, India Source Type: research

Natural products as a source of new anticancer chemotypes
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 30, 2023 Category: Drugs & Pharmacology Authors: Francesco MelfiSimone CarradoriNoemi MencarelliCristina CampestreMarialucia GalloriniSilvia Di GiacomoAntonella Di Sottoa Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italyb Department of Physiology and Pharmacology Source Type: research

Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020 –2022 patent update
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 22, 2023 Category: Drugs & Pharmacology Authors: Carolin JaworskiPetar IlievCarmen W änglerBjörn WänglerBrent PageRalf SchirrmacherJustin J. Baileya Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canadab Faculty of Pharmaceutical Sciences, University of British Colum Source Type: research

An updated patent review of metallo- β-lactamase inhibitors (2020–2023)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 22, 2023 Category: Drugs & Pharmacology Authors: Elsa DenakpoThierry NaasBogdan I. Iorgaa Universit é Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, Franceb Team ReSIST, INSERM U1184, School of Medicine Université Paris-Saclay, LabEx LERMIT, Le Kremlin-Bicêtre, Fran Source Type: research

CDC7 kinase inhibitors: a survey of recent patent literature (2017 –2022)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - September 22, 2023 Category: Drugs & Pharmacology Authors: Takayuki IrieMasaaki SawaDrug Discovery and Development, Carna Biosciences, Inc, Kobe, Japan Source Type: research

Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 12, 2023 Category: Drugs & Pharmacology Authors: Claudiu T Supuran Source Type: research

A patent review of MAPK inhibitors (2018 – present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 1, 2023 Category: Drugs & Pharmacology Authors: Valentin R Wydra Raphael B Ditzinger Nico J Seidler Frederik W Hacker Stefan A Laufer Source Type: research